{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:58Z","timestamp":1791928978293,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtm.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T18:51:52Z","timestamp":1565981512000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1"],"prefix":"10.1016","volume":"15","author":[{"given":"Shilpa","family":"Prabhakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pike See","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Zinter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gianatasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick T.","family":"Bronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Stemmer-Rachamimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey A.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sena-Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakhos A.","family":"Tannous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xandra O.","family":"Breakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.08.003_bib1","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtm.2019.08.003_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","article-title":"A complex interplay between Akt, TSC2 and the two mTOR complexes","volume":"37","author":"Huang","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.omtm.2019.08.003_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-013-1085-x","article-title":"Evolving neurobiology of tuberous sclerosis complex","volume":"125","author":"Crino","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtm.2019.08.003_bib4","series-title":"Tuberous Sclerosis Complex: Genes, Clinical Features, and Therapeutics","author":"Kwiatkowski","year":"2010"},{"key":"10.1016\/j.omtm.2019.08.003_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0733-8619(03)00004-5","article-title":"Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases","volume":"21","author":"Kandt","year":"2003","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.omtm.2019.08.003_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10519-012-9571-9","article-title":"Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL\/6 mice","volume":"43","author":"Tsai","year":"2013","journal-title":"Behav. Genet."},{"key":"10.1016\/j.omtm.2019.08.003_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2018.02.021","article-title":"Dendrite growth and the effect of ectopic Rheb expression on cortical neurons","volume":"671","author":"Sokolov","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtm.2019.08.003_bib8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.08.003_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.018","article-title":"Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model","volume":"82","author":"Prabhakar","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2019.08.003_bib10","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2019.08.003_bib11","doi-asserted-by":"crossref","first-page":"e64224","DOI":"10.1371\/journal.pone.0064224","article-title":"Stochastic model of Tsc1 lesions in mouse brain","volume":"8","author":"Prabhakar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.08.003_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2019.08.003_bib13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/mt.2014.68","article-title":"Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10","volume":"22","author":"Yang","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.08.003_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuroscience.2005.11.057","article-title":"Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain","volume":"138","author":"Broekman","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtm.2019.08.003_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0192623310389621","article-title":"Histology of the central nervous system","volume":"39","author":"Garman","year":"2011","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omtm.2019.08.003_bib16","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.08.003_bib17","doi-asserted-by":"crossref","first-page":"eaan4672","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","volume":"359","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.08.003_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtm.2019.08.003_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2017.06.021","article-title":"Rapamycin decreased blood-brain barrier permeability in control but not in diabetic rats in early cerebral ischemia","volume":"654","author":"Chi","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.omtm.2019.08.003_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.transproceed.2017.12.003","article-title":"Life-threatening everolimus-associated pneumonitis: a case report and a review of the literature","volume":"50","author":"Almeida","year":"2018","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.omtm.2019.08.003_bib21","first-page":"377","article-title":"Mammalian target of rapamycin inhibitors and nephrotoxicity: fact or fiction","volume":"13","author":"Barbari","year":"2015","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.omtm.2019.08.003_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1024\/0040-5930\/a000230","article-title":"[Immunosuppressive drugs\u2014how they work, their side effects and interactions]","volume":"68","author":"Stucker","year":"2011","journal-title":"Ther. Umsch."},{"key":"10.1016\/j.omtm.2019.08.003_bib23","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1093\/hmg\/dds156","article-title":"The differential effects of prenatal and\/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex","volume":"21","author":"Way","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.08.003_bib24","doi-asserted-by":"crossref","first-page":"7082696","DOI":"10.1155\/2017\/7082696","article-title":"mTOR-dependent cell proliferation in the brain","volume":"2017","author":"Ryskalin","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.omtm.2019.08.003_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/08830738040190090401","article-title":"Brain abnormalities in tuberous sclerosis complex","volume":"19","author":"DiMario","year":"2004","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.omtm.2019.08.003_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pediatrneurol.2013.12.004","article-title":"Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients","volume":"50","author":"Kotulska","year":"2014","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.omtm.2019.08.003_bib27","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1523\/JNEUROSCI.1840-12.2013","article-title":"Rheb activation in subventricular zone progenitors leads to heterotopia, ectopic neuronal differentiation, and rapamycin-sensitive olfactory micronodules and dendrite hypertrophy of newborn neurons","volume":"33","author":"Lafourcade","year":"2013","journal-title":"J.\u00a0Neurosci"},{"key":"10.1016\/j.omtm.2019.08.003_bib28","article-title":"Advances in spinal muscular atrophy therapeutics","volume":"11","author":"Parente","year":"2018","journal-title":"Ther. Adv. Neurol. Disorder."},{"key":"10.1016\/j.omtm.2019.08.003_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jviromet.2004.08.017","article-title":"Optimized large-scale production of high titer lentivirus vector pseudotypes","volume":"122","author":"Sena-Esteves","year":"2004","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2019.08.003_bib30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2019.08.003_bib31","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1073\/pnas.96.9.5037","article-title":"Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice","volume":"96","author":"Mao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.08.003_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/laban0511-155","article-title":"Retro-orbital injections in mice","volume":"40","author":"Yardeni","year":"2011","journal-title":"Lab Anim. (NY)"},{"key":"10.1016\/j.omtm.2019.08.003_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat. Neurosci"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905011930083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S232905011930083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:24:30Z","timestamp":1762421070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S232905011930083X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":33,"alternative-id":["S232905011930083X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.08.003","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}